The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians

Stephanie Heux, Fabien Morin, Rod A. Lea, Micky Ovcaric, Lofti Tajouri, Lyn R. Griffiths

Research output: Contribution to journalArticleResearchpeer-review

35 Citations (Scopus)

Abstract

Essential hypertension (EH) is a common, multifactorial disorder likely to be influenced by multiple genes of modest effect. The methylenetetrahydrofolate reductase (MTHFR) gene C677T mutation is functionally important, being strongly associated with reduced enzyme activity and increased plasma levels of homocysteine. Mild hyperhomocysteinemia is a known risk factor for cardiovascular disease (CVD) and hypothesised also to be involved in hypertension pathophysiology. The present study was performed to determine the prevalence of the 677T mutation in Australian Caucasian patients diagnosed with EH and to test whether the C677T variant is associated with the disorder. A case-control cohort, consisting of 250 EH patients and 250 age, sex and racially matched normotensive controls, were used for the association study. Comparison of C677T allele frequencies revealed a higher proportion of the mutant allele (T) in the EH group (40%) compared to unaffected controls (34%) (p=0.07). Furthermore, genotypic results indicated that the prevalence of the homozygous mutant genotype (T/T) in the affected group was higher than that of controls (14%:10%) (p=0.17). Interestingly, conditional logistic regression showed that the MTHFR C677T mutation conferred a mild, yet significant increase in risk of essential hypertension after adjusting for body mass index (odds ratio=1.57, 95% confidence interval: 1.04-2.37, p=0.03). These findings require further investigation in large independent samples, but suggest that essential hypertension, like CVD, may be mildly influenced by the MTHFR C677T variant.

Original languageEnglish
Pages (from-to)663-667
Number of pages5
JournalHypertension Research
Volume27
Issue number9
DOIs
Publication statusPublished - Sep 2004
Externally publishedYes

Fingerprint

Oxidoreductases
Methylenetetrahydrofolate Reductase (NADPH2)
Genes
Mutation
Cardiovascular Diseases
Hyperhomocysteinemia
Homocysteine
Gene Frequency
Essential Hypertension
Body Mass Index
Logistic Models
Alleles
Odds Ratio
Genotype
Confidence Intervals
Hypertension
Enzymes

Cite this

Heux, Stephanie ; Morin, Fabien ; Lea, Rod A. ; Ovcaric, Micky ; Tajouri, Lofti ; Griffiths, Lyn R. / The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. In: Hypertension Research. 2004 ; Vol. 27, No. 9. pp. 663-667.
@article{47a4781106ab44e48dd3d82f4e1b6e61,
title = "The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians",
abstract = "Essential hypertension (EH) is a common, multifactorial disorder likely to be influenced by multiple genes of modest effect. The methylenetetrahydrofolate reductase (MTHFR) gene C677T mutation is functionally important, being strongly associated with reduced enzyme activity and increased plasma levels of homocysteine. Mild hyperhomocysteinemia is a known risk factor for cardiovascular disease (CVD) and hypothesised also to be involved in hypertension pathophysiology. The present study was performed to determine the prevalence of the 677T mutation in Australian Caucasian patients diagnosed with EH and to test whether the C677T variant is associated with the disorder. A case-control cohort, consisting of 250 EH patients and 250 age, sex and racially matched normotensive controls, were used for the association study. Comparison of C677T allele frequencies revealed a higher proportion of the mutant allele (T) in the EH group (40{\%}) compared to unaffected controls (34{\%}) (p=0.07). Furthermore, genotypic results indicated that the prevalence of the homozygous mutant genotype (T/T) in the affected group was higher than that of controls (14{\%}:10{\%}) (p=0.17). Interestingly, conditional logistic regression showed that the MTHFR C677T mutation conferred a mild, yet significant increase in risk of essential hypertension after adjusting for body mass index (odds ratio=1.57, 95{\%} confidence interval: 1.04-2.37, p=0.03). These findings require further investigation in large independent samples, but suggest that essential hypertension, like CVD, may be mildly influenced by the MTHFR C677T variant.",
author = "Stephanie Heux and Fabien Morin and Lea, {Rod A.} and Micky Ovcaric and Lofti Tajouri and Griffiths, {Lyn R.}",
year = "2004",
month = "9",
doi = "10.1291/hypres.27.663",
language = "English",
volume = "27",
pages = "663--667",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "9",

}

The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. / Heux, Stephanie; Morin, Fabien; Lea, Rod A.; Ovcaric, Micky; Tajouri, Lofti; Griffiths, Lyn R.

In: Hypertension Research, Vol. 27, No. 9, 09.2004, p. 663-667.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians

AU - Heux, Stephanie

AU - Morin, Fabien

AU - Lea, Rod A.

AU - Ovcaric, Micky

AU - Tajouri, Lofti

AU - Griffiths, Lyn R.

PY - 2004/9

Y1 - 2004/9

N2 - Essential hypertension (EH) is a common, multifactorial disorder likely to be influenced by multiple genes of modest effect. The methylenetetrahydrofolate reductase (MTHFR) gene C677T mutation is functionally important, being strongly associated with reduced enzyme activity and increased plasma levels of homocysteine. Mild hyperhomocysteinemia is a known risk factor for cardiovascular disease (CVD) and hypothesised also to be involved in hypertension pathophysiology. The present study was performed to determine the prevalence of the 677T mutation in Australian Caucasian patients diagnosed with EH and to test whether the C677T variant is associated with the disorder. A case-control cohort, consisting of 250 EH patients and 250 age, sex and racially matched normotensive controls, were used for the association study. Comparison of C677T allele frequencies revealed a higher proportion of the mutant allele (T) in the EH group (40%) compared to unaffected controls (34%) (p=0.07). Furthermore, genotypic results indicated that the prevalence of the homozygous mutant genotype (T/T) in the affected group was higher than that of controls (14%:10%) (p=0.17). Interestingly, conditional logistic regression showed that the MTHFR C677T mutation conferred a mild, yet significant increase in risk of essential hypertension after adjusting for body mass index (odds ratio=1.57, 95% confidence interval: 1.04-2.37, p=0.03). These findings require further investigation in large independent samples, but suggest that essential hypertension, like CVD, may be mildly influenced by the MTHFR C677T variant.

AB - Essential hypertension (EH) is a common, multifactorial disorder likely to be influenced by multiple genes of modest effect. The methylenetetrahydrofolate reductase (MTHFR) gene C677T mutation is functionally important, being strongly associated with reduced enzyme activity and increased plasma levels of homocysteine. Mild hyperhomocysteinemia is a known risk factor for cardiovascular disease (CVD) and hypothesised also to be involved in hypertension pathophysiology. The present study was performed to determine the prevalence of the 677T mutation in Australian Caucasian patients diagnosed with EH and to test whether the C677T variant is associated with the disorder. A case-control cohort, consisting of 250 EH patients and 250 age, sex and racially matched normotensive controls, were used for the association study. Comparison of C677T allele frequencies revealed a higher proportion of the mutant allele (T) in the EH group (40%) compared to unaffected controls (34%) (p=0.07). Furthermore, genotypic results indicated that the prevalence of the homozygous mutant genotype (T/T) in the affected group was higher than that of controls (14%:10%) (p=0.17). Interestingly, conditional logistic regression showed that the MTHFR C677T mutation conferred a mild, yet significant increase in risk of essential hypertension after adjusting for body mass index (odds ratio=1.57, 95% confidence interval: 1.04-2.37, p=0.03). These findings require further investigation in large independent samples, but suggest that essential hypertension, like CVD, may be mildly influenced by the MTHFR C677T variant.

UR - http://www.scopus.com/inward/record.url?scp=8844244056&partnerID=8YFLogxK

U2 - 10.1291/hypres.27.663

DO - 10.1291/hypres.27.663

M3 - Article

VL - 27

SP - 663

EP - 667

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 9

ER -